[go: up one dir, main page]

Bril, 2003 - Google Patents

Factor VIII inhibitors in mild haemophilia A

Bril, 2003

View PDF
Document ID
5840015253163507368
Author
Bril W
Publication year

External Links

Snippet

The X-linked bleeding disorder haemophilia A is due to a deficiency or functional defect of coagulation factor VIII. The bleeding tendency can be corrected by administration of factor VIII concentrates. A serious complication of factor VIII replacement therapy is the …
Continue reading at dspace.library.uu.nl (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin

Similar Documents

Publication Publication Date Title
CN114539414A (en) Anti-coagulation factor XI antibodies
JP4660189B2 (en) Compositions, methods and kits related to antiplatelet autoantibodies and inhibitors thereof
van den Brink et al. Human antibodies with specificity for the C2 domain of factor VIII are derived from VH1 germline genes
JP2009528285A (en) Anti-idiotype antibody neutralizing inhibitory activity of inhibitory antibody against C1 domain of factor VIII
TW201802120A (en) Anticoagulant factor XI antibody
Van den Brink et al. Two classes of germline genes both derived from the VH1 family direct the formation of human antibodies that recognize distinct antigenic sites in the C2 domain of factor VIII
BR112020010016A2 (en) reversal binding agents for anti-factor xi / xia antibodies and their uses
Spatz et al. Cloning and sequence analysis of the VH and VL regions of an anti-myelin/DNA antibody from a patient with peripheral neuropathy and chronic lymphocytic leukemia.
van den Brink et al. Multiple VH genes are used to assemble human antibodies directed toward the A3-C1 domains of factor VIII
Mo et al. The B cell response to autologous type II collagen: biased V gene repertoire with V gene sharing and epitope shift.
US20080206254A1 (en) Novel Anti-Factor VIII Antibodies
van den Brink et al. Molecular analysis of human anti-factor VIII antibodies by V gene phage display identifies a new epitope in the acidic region following the A2 domain: Presented in part at the 41st Annual Meeting of the American Society of Hematology, December 3-7, 1999, New Orleans, LA.
CA2551317A1 (en) Anti-idiotypic antibody neutralizing the inhibitory action of an inhibitory antibody for factor viii
KR100925348B1 (en) Human-type anti-blood coagulation factor ? antibody
CA2327587C (en) Methods for treatment of haemophilia a patients using human anti-human fviii antibodies
Bril Factor VIII inhibitors in mild haemophilia A
CA2494698C (en) Anti-idiotypic antibodies against factor viii inhibitor and uses thereof
Clausen et al. Clonally-related immunoglobulin VH domains and nonrandom use of DH gene segments in rheumatoid arthritis synovium
Voorberg et al. Phage display technology: a tool to explore the diversity of inhibitors to blood coagulation factor VIII
Watkins et al. Molecular studies of anti‐HLA‐A2 using light‐chain shuffling: a structural model for HLA antibody binding
Devaux et al. Preferential expression of VK21E light chains on IdX Ia. 7 positive monoclonal anti-IE antibodies.
Stewart et al. Rhesus monkeys and baboons develop clotting factor VIII inhibitors in response to porcine endothelial cells or islets
Gharagozlou et al. Characterization of human hybridoma clones isolated from hemophilia patients with specificity for different domains of coagulating factor VIII
Lönnblom Antibodies as pathogenic factors and biomarkers in rheumatoid arthritis
Mouse Major Cross-Reactive Idiotype of the